Business Standard

Jagsonpal Pharmaceuticals reports nil net profit/loss in the June 2013 quarter

Image

Capital Market

Sales rise 2.28% to Rs 38.08 crore

Jagsonpal Pharmaceuticals reported no net profit/loss in the quarter ended June 2013 and during the previous quarter ended June 2012. Sales rose 2.28% to Rs 38.08 crore in the quarter ended June 2013 as against Rs 37.23 crore during the previous quarter ended June 2012. ParticularsQuarter EndedJun. 2013Jun. 2012% Var.Sales38.0837.23 2 OPM %5.385.26 -PBDT0.700.80 -13 PBT0.010.15 -93 NP00 0

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 21 2013 | 10:17 AM IST

Explore News